Invention Grant
- Patent Title: MAGE3 polypeptides
- Patent Title (中): MAGE3多肽
-
Application No.: US12640306Application Date: 2009-12-17
-
Publication No.: US08097257B2Publication Date: 2012-01-17
- Inventor: Teresa Cabezon Sil Va , Joseph Cohen , Moncef Mohamed Slaoui , Carlota Vinals Bassols
- Applicant: Teresa Cabezon Sil Va , Joseph Cohen , Moncef Mohamed Slaoui , Carlota Vinals Bassols
- Applicant Address: BE Rixensart
- Assignee: GlaxoSmithKline Biologicals S.A.
- Current Assignee: GlaxoSmithKline Biologicals S.A.
- Current Assignee Address: BE Rixensart
- Agent Virginia G. Campen
- Priority: GB9802543.0 19980205; GB9802650.3 19980206
- Main IPC: A61K38/17
- IPC: A61K38/17 ; C07K1/06 ; C07K14/465 ; C07K14/705
Abstract:
The present invention relates to novel MAGE3 polypeptides, including a fragment of MAGE3 fused to an immunological fusion partner, and compositions thereof.
Public/Granted literature
- US20100209444A1 MAGE3 Polypeptides Public/Granted day:2010-08-19
Information query
IPC分类:
